Cargando…

Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis

BACKGROUND AND OBJECTIVE: Inhalational exposures are a known cause of interstitial lung disease (ILD), but little is understood about their prevalence across ILD subtypes and their relationship with pulmonary function and survival. METHODS: Patients with fibrotic ILD were identified from the multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Cathryn T., Strek, Mary E., Adegunsoye, Ayodeji, Wong, Alyson W., Assayag, Deborah, Cox, Gerard, Fell, Charlene D., Fisher, Jolene H., Gershon, Andrea S., Halayko, Andrew J., Hambly, Nathan, Khalil, Nasreen, Kolb, Martin, Lok, Stacey D., Manganas, Hélène, Marcoux, Veronica, Morisset, Julie, Sadatsafavi, Mohsen, Shapera, Shane, To, Teresa, Wilcox, Pearce, Ryerson, Christopher J., Johannson, Kerri A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296585/
https://www.ncbi.nlm.nih.gov/pubmed/35512793
http://dx.doi.org/10.1111/resp.14267
_version_ 1784750302592761856
author Lee, Cathryn T.
Strek, Mary E.
Adegunsoye, Ayodeji
Wong, Alyson W.
Assayag, Deborah
Cox, Gerard
Fell, Charlene D.
Fisher, Jolene H.
Gershon, Andrea S.
Halayko, Andrew J.
Hambly, Nathan
Khalil, Nasreen
Kolb, Martin
Lok, Stacey D.
Manganas, Hélène
Marcoux, Veronica
Morisset, Julie
Sadatsafavi, Mohsen
Shapera, Shane
To, Teresa
Wilcox, Pearce
Ryerson, Christopher J.
Johannson, Kerri A.
author_facet Lee, Cathryn T.
Strek, Mary E.
Adegunsoye, Ayodeji
Wong, Alyson W.
Assayag, Deborah
Cox, Gerard
Fell, Charlene D.
Fisher, Jolene H.
Gershon, Andrea S.
Halayko, Andrew J.
Hambly, Nathan
Khalil, Nasreen
Kolb, Martin
Lok, Stacey D.
Manganas, Hélène
Marcoux, Veronica
Morisset, Julie
Sadatsafavi, Mohsen
Shapera, Shane
To, Teresa
Wilcox, Pearce
Ryerson, Christopher J.
Johannson, Kerri A.
author_sort Lee, Cathryn T.
collection PubMed
description BACKGROUND AND OBJECTIVE: Inhalational exposures are a known cause of interstitial lung disease (ILD), but little is understood about their prevalence across ILD subtypes and their relationship with pulmonary function and survival. METHODS: Patients with fibrotic ILD were identified from the multicentre Canadian Registry for Pulmonary Fibrosis. Patients completed questionnaires regarding ILD‐related occupational and environmental exposures. The relationship between exposures and the outcomes of baseline age, gender, family history, pulmonary function and survival was analysed using linear and logistic regression models, linear mixed‐effect regression models and survival analysis using multivariable Cox proportional hazards along with the log‐rank test. RESULTS: There were 3820 patients included in this study, with 2385 (62%) having ILD‐related inhalational exposure. Exposed patients were younger, particularly in the idiopathic pulmonary fibrosis subgroup. Inhalational exposure was associated with male gender (adjusted OR 1.46, 95% CI 1.28–1.68, p < 0.001) and family history of pulmonary fibrosis (adjusted OR 1.73, 95% CI 1.40–2.15, p < 0.001). Patients with any inhalational exposure had improved transplant‐free survival (hazard ratio 0.81, 95% CI 0.71–0.92, p = 0.001); this effect persisted across diagnostic subtypes. The relationship between exposures and annual change in forced vital capacity varied by ILD subtype. CONCLUSION: Patients with fibrotic ILD report high prevalence of inhalational exposures across ILD subtypes. These exposures were associated with younger age at diagnosis, male gender and family history of pulmonary fibrosis. Identification of an inhalational exposure was associated with a survival benefit. These findings suggest that inhaled exposures may impact clinical outcomes in patients with ILD, and future work should characterize the mechanisms underlying these relationships.
format Online
Article
Text
id pubmed-9296585
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-92965852022-10-14 Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis Lee, Cathryn T. Strek, Mary E. Adegunsoye, Ayodeji Wong, Alyson W. Assayag, Deborah Cox, Gerard Fell, Charlene D. Fisher, Jolene H. Gershon, Andrea S. Halayko, Andrew J. Hambly, Nathan Khalil, Nasreen Kolb, Martin Lok, Stacey D. Manganas, Hélène Marcoux, Veronica Morisset, Julie Sadatsafavi, Mohsen Shapera, Shane To, Teresa Wilcox, Pearce Ryerson, Christopher J. Johannson, Kerri A. Respirology ORIGINAL ARTICLES BACKGROUND AND OBJECTIVE: Inhalational exposures are a known cause of interstitial lung disease (ILD), but little is understood about their prevalence across ILD subtypes and their relationship with pulmonary function and survival. METHODS: Patients with fibrotic ILD were identified from the multicentre Canadian Registry for Pulmonary Fibrosis. Patients completed questionnaires regarding ILD‐related occupational and environmental exposures. The relationship between exposures and the outcomes of baseline age, gender, family history, pulmonary function and survival was analysed using linear and logistic regression models, linear mixed‐effect regression models and survival analysis using multivariable Cox proportional hazards along with the log‐rank test. RESULTS: There were 3820 patients included in this study, with 2385 (62%) having ILD‐related inhalational exposure. Exposed patients were younger, particularly in the idiopathic pulmonary fibrosis subgroup. Inhalational exposure was associated with male gender (adjusted OR 1.46, 95% CI 1.28–1.68, p < 0.001) and family history of pulmonary fibrosis (adjusted OR 1.73, 95% CI 1.40–2.15, p < 0.001). Patients with any inhalational exposure had improved transplant‐free survival (hazard ratio 0.81, 95% CI 0.71–0.92, p = 0.001); this effect persisted across diagnostic subtypes. The relationship between exposures and annual change in forced vital capacity varied by ILD subtype. CONCLUSION: Patients with fibrotic ILD report high prevalence of inhalational exposures across ILD subtypes. These exposures were associated with younger age at diagnosis, male gender and family history of pulmonary fibrosis. Identification of an inhalational exposure was associated with a survival benefit. These findings suggest that inhaled exposures may impact clinical outcomes in patients with ILD, and future work should characterize the mechanisms underlying these relationships. John Wiley & Sons, Ltd 2022-05-05 2022-08 /pmc/articles/PMC9296585/ /pubmed/35512793 http://dx.doi.org/10.1111/resp.14267 Text en © 2022 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle ORIGINAL ARTICLES
Lee, Cathryn T.
Strek, Mary E.
Adegunsoye, Ayodeji
Wong, Alyson W.
Assayag, Deborah
Cox, Gerard
Fell, Charlene D.
Fisher, Jolene H.
Gershon, Andrea S.
Halayko, Andrew J.
Hambly, Nathan
Khalil, Nasreen
Kolb, Martin
Lok, Stacey D.
Manganas, Hélène
Marcoux, Veronica
Morisset, Julie
Sadatsafavi, Mohsen
Shapera, Shane
To, Teresa
Wilcox, Pearce
Ryerson, Christopher J.
Johannson, Kerri A.
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
title Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
title_full Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
title_fullStr Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
title_full_unstemmed Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
title_short Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
title_sort inhalational exposures in patients with fibrotic interstitial lung disease: presentation, pulmonary function and survival in the canadian registry for pulmonary fibrosis
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296585/
https://www.ncbi.nlm.nih.gov/pubmed/35512793
http://dx.doi.org/10.1111/resp.14267
work_keys_str_mv AT leecathrynt inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT strekmarye inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT adegunsoyeayodeji inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT wongalysonw inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT assayagdeborah inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT coxgerard inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT fellcharlened inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT fisherjoleneh inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT gershonandreas inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT halaykoandrewj inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT hamblynathan inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT khalilnasreen inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT kolbmartin inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT lokstaceyd inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT manganashelene inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT marcouxveronica inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT morissetjulie inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT sadatsafavimohsen inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT shaperashane inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT toteresa inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT wilcoxpearce inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT ryersonchristopherj inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis
AT johannsonkerria inhalationalexposuresinpatientswithfibroticinterstitiallungdiseasepresentationpulmonaryfunctionandsurvivalinthecanadianregistryforpulmonaryfibrosis